Kaitlyn Sizemore
Physician Assistant · Eaton, OHNPI 1891163580
Payments from drug & device makers
Across 344 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$902
- Novo Nordisk$693
- AbbVie$668
- Johnson & Johnson$388
- Astellas Pharma US Inc$382
- Alkermes, Inc.$217
- plus $2K from 40 others
What the payments were for
- Food & beverage$5,56297%
- Education$1663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,727 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 60 | $72,684 |
| FarxigaDapagliflozin Propanediol | 72 | $70,098 |
| EliquisApixaban | 58 | $46,428 |
| OzempicSemaglutide | 33 | $46,289 |
| MyrbetriqMirabegron | 44 | $29,452 |
| JardianceEmpagliflozin | 34 | $25,727 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 32 | $21,551 |
| XareltoRivaroxaban | 15 | $19,590 |
| LinzessLinaclotide | 24 | $19,294 |
| VascepaIcosapent Ethyl | 13 | $9,828 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 49 | $9,058 |
| GemtesaVibegron | 18 | $8,794 |
| Repatha SureclickEvolocumab | 14 | $7,883 |
| LantusInsulin Glargine,hum.Rec.Anlog | 15 | $2,396 |
| Atorvastatin Calcium | 301 | $2,298 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $902 | $91,650104 claims |
| Lilly USA, LLCMounjaro | $175 | $72,68460 claims |
| PfizerEliquis | $137 | $46,42858 claims |
| Novo NordiskOzempic | $693 | $46,28933 claims |
| Astellas Pharma US IncMyrbetriq | $382 | $29,45244 claims |
| Boehringer IngelheimJardiance | $77 | $25,72734 claims |
| AbbVieLinzess, Synthroid | $668 | $20,47749 claims |
| Johnson & JohnsonXarelto | $388 | $19,59015 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $61 | $8,79418 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Eaton
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Alan OdonnellCincinnati$71K
- Brook GramBeloit$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.